Product Information
ARNUITY ELLIPTA 100 MCG INH is a brand product labeled by GlaxoSmithKline LLC, priced at $6.6476 per EA under NDC 00173087414. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Aug 20, 2014.
Strength
100 ug/1
Manufacturer
GlaxoSmithKline LLCNDC
00173087414
Classification
Brand
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
FLUTICASONE FUROATEApproval Type
New Drug (NDA)
FDA Application
NDA205625FDA Approved
8/20/2014
On Market Since
8/20/2014
Pharmacological Classes
Price Statistics
The NADAC for ARNUITY ELLIPTA 100 MCG INH has been published 123 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6476 per EA |
|---|---|
| All-time high | $6.6932 (Aug 13, 2025) |
| All-time low | $6.6349 (Sep 18, 2024) |
| 52-week high | $6.6928 |
| 52-week low | $6.6476 |
| Median price | $6.6692 |
| Average price | $6.6688 |
| Largest weekly change | +0.4% (Jul 23, 2025) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ARNUITY ELLIPTA 100 MCG INH?
The current National Average Drug Acquisition Cost (NADAC) for ARNUITY ELLIPTA 100 MCG INH, manufactured by GlaxoSmithKline LLC, is $6.6476 per EA (NDC 00173087414), effective Aug 19, 2026.
How has the price of ARNUITY ELLIPTA 100 MCG INH changed over time?
Over the history we have for it, the NADAC for ARNUITY ELLIPTA 100 MCG INH has held within roughly two percent of its current level. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for ARNUITY ELLIPTA 100 MCG INH?
Since Apr 17, 2024, the NADAC for ARNUITY ELLIPTA 100 MCG INH has ranged from a low of $6.6349 (Sep 18, 2024) to a high of $6.6932 (Aug 13, 2025), with a median of $6.6692 per EA.
Are there cheaper alternatives to ARNUITY ELLIPTA 100 MCG INH?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FLUTICASONE ELLIPTA 100 MCG INH, is $4.2969 per EA — about 35% below ARNUITY ELLIPTA 100 MCG INH.
Who manufactures ARNUITY ELLIPTA 100 MCG INH?
ARNUITY ELLIPTA 100 MCG INH (NDC 00173087414) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.